Valuation (24%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 31.99 | -17.63 |
PEG Ratio (TTM) | 0.04 | -5.48 |
P/S Ratio (TTM) | N/A | 34.87 |
P/B Ratio (TTM) | -43.54 | 5.70 |
P/FCF Ratio (TTM) | -88.79 | -147.76 |
Price to 5YR AVG Earnings Ratio | N/A | -33.79 |
Price to 5YR AVG FCF Ratio | N/A | -1.30 |
Profitability (40%) |
Company | Industry |
---|---|---|
ROA (TTM) | 20.01% | 286.91% |
ROE (TTM) | 15.66% | -4,214.54% |
Net Profit Margin (TTM) | N/A | -1,036.97% |
ROIC 5YR AVG | N/A | -16.05% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 246.48% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | 251.42% | N/A | N/A |
Cash Flow | -42.22% | N/A | N/A |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.55 | 4.93 |
Quick Ratio (TTM) | 0.55 | 4.91 |
D/E Ratio (TTM) | N/A | 1.25 |
Interest Coverage (TTM) | -0.54 | -11.14 |
Piotroski F-Score | 4 | 3 |
Altman Z-Score | 20.95 | 20.93 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 887.69% |